SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042444
Filing Date
2018-08-07
Accepted
2018-08-07 16:17:13
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv498930_10q.htm 10-Q 595797
2 EXHIBIT 31.1 tv498930_ex31-1.htm EX-31.1 11537
3 EXHIBIT 31.2 tv498930_ex31-2.htm EX-31.2 12160
4 EXHIBIT 32.1 tv498930_ex32-1.htm EX-32.1 5876
  Complete submission text file 0001144204-18-042444.txt   4953748

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20180630.xml EX-101.INS 1127390
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20180630.xsd EX-101.SCH 42867
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20180630_cal.xml EX-101.CAL 46702
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20180630_def.xml EX-101.DEF 317207
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20180630_lab.xml EX-101.LAB 326568
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20180630_pre.xml EX-101.PRE 349301
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 18998314
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences